Sarepta Therapeutics, Inc. Financial Ratios — SRPT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	-156.81	-60.39	-54.88	-100.47	-101.42	-9	-39.74	-77.29	-70.15	-49.57	-107.16	-86.15	19.71	-53.47
Return on Assets (%)	-4.62	-93.53	-45.1	-46.3	-77.36	-76.59	-5.85	-24.54	-41.28	-23.05	-13.66	-22.42	-16.77	6.51	-19.51
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.82	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.63	- -
Gross Margin (%)	100	100	100	100	100	98.14	95.24	88.64	85.14	88.26	86.17	85	87.91	83.22	61.81
EBITDA Margin (%)	-73.69	-75.49	-625.97	-1,333.39	-17,153.79	-4,769.8	-87.41	-110.08	-130.72	-99.47	-58.66	-52.98	-17.97	13.45	-27.9
Operating Margin (%)	-76.46	-79.57	-634.95	-1,371.21	-17,572.55	-4,873.31	-92.64	-114.15	-137.15	-104.46	-64.07	-57.47	-21.54	11.47	-29.92
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	73.77	- -
Pretax Margin (%)	-4.93	-324.91	-787.57	-1,391.71	-17,560.26	-4,930.18	-31.46	-120.45	-187.45	-102.4	-59.69	-73.95	-41.83	13.71	-31.94
Profit Margin (%)	-4.93	-324.91	-787.57	-1,391.71	-17,560.26	-4,930.18	-32.79	-120.22	-187.77	-102.6	-59.66	-75.4	-43.11	12.37	-32.45
Net Income to Common Margin (%)	-4.93	-324.91	-787.57	-1,391.71	-17,560.26	-4,930.18	-32.79	-120.22	-187.77	-102.6	-59.66	-75.4	-43.11	12.37	-32.45
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.79	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	-156.81	-60.39	-54.88	-100.47	-101.42	-9	-39.74	-77.29	-70.15	-49.57	-107.16	-86.15	19.71	-53.47

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	2	2	2	6	23	16	431	421	730	1,073	1,153	1,617	1,397	1,343	1,040
ST Debt	- -	- -	- -	3	8	10	6	- -	- -	- -	15	15	123	13	11
LT Debt	2	2	2	4	15	6	425	421	730	1,073	1,138	1,602	1,273	1,330	1,028
Total Debt/EBITDA	-0.05	-0.06	-0.02	-0.05	-0.11	-0.06	-3.19	-1.27	-1.47	-2	-2.8	-3.27	-6.25	5.25	-1.7
Net Debt/EBITDA	1.1	6.6	2.87	0.52	0.26	0.41	1.25	-0.15	0.31	0.95	2.48	-1.17	-3.62	0.13	-0.05
Total Debt/EBIT	-0.05	-0.06	-0.02	-0.05	-0.11	-0.06	-3.01	-1.22	-1.4	-1.9	-2.56	-3.02	-5.22	6.16	-1.58
Net Debt/EBIT	1.06	6.26	2.83	0.5	0.26	0.4	1.18	-0.14	0.29	0.9	2.27	-1.08	-3.02	0.16	-0.04
EBITDA to Interest Expense	-384.74	- -	- -	- -	-157.46	-136.67	-23.29	-9.83	-16.23	-8.96	-6.48	-9.28	-10.15	13.91	-16.08
EBITDA-CapEx/Interest Expense	-410.36	- -	- -	- -	-161	-140.29	-26.95	-11.74	-18.28	-10.33	-7.12	-9.89	-14.12	5.92	-18.96
EBIT to Interest Expense	-399.19	- -	- -	- -	-161.31	-139.63	-24.69	-10.19	-17.03	-9.41	-7.08	-10.07	-12.17	11.86	-17.25
Interest Expense	- -	- -	- -	- -	1	2	6	34	31	60	64	53	22	18	38
Common Equity/Total Assets	57.05	60.33	84.78	83.94	69.53	79.39	60.34	62.86	44.89	25.52	29.48	12.31	26.32	38.55	34.05
Long-Term Debt/Equity (%)	5.66	1.35	0.64	1.51	7.86	1.79	53.84	40.74	89.18	140.84	122.67	416.12	148.19	87.03	90.16
Long-Term Debt/Capital (%)	5.35	1.33	0.63	1.47	7	1.71	34.82	28.95	47.14	58.48	54.69	80	56.44	46.31	47.16
Long-Term Debt/Total Assets (%)	3.23	0.81	0.54	1.27	5.47	1.42	32.48	25.61	40.03	35.95	36.16	51.2	39.01	33.55	30.7
Total Debt/Equity (%)	5.94	1.42	0.67	2.56	12.29	4.8	54.62	40.74	89.18	140.84	124.29	420.15	162.54	87.91	91.16
Total Debt/Capital (%)	5.61	1.4	0.67	2.49	10.95	4.58	35.32	28.95	47.14	58.48	55.42	80.77	61.91	46.78	47.69
Total Debt/Total Assets (%)	3.39	0.86	0.57	2.14	8.55	3.81	32.96	25.61	40.03	35.95	36.64	51.7	42.79	33.89	31.04
Net Debt to Equity	-122.71	-150.31	-103.28	-27.14	-29.9	-31.56	-21.37	4.82	-18.72	-66.97	-109.8	150.02	94.21	2.23	2.43
Net Debt/Capital (%)	540.27	298.76	3,149.87	-37.26	-42.65	-46.12	-27.17	4.6	-21.49	-153.67	2,960.38	55.77	44.29	1.93	2.01
EBITDA	-35	-28	-89	-130	-215	-259	-135	-331	-498	-537	-412	-494	-223	256	-613
EBITDA-CapEx	-37	-29	-93	-157	-220	-265	-156	-396	-561	-619	-452	-527	-311	109	-723
Operating Income (Loss)	-36	-30	-90	-134	-220	-264	-143	-344	-522	-564	-450	-536	-268	218	-658

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	1.94	2.38	7.14	5.71	3.09	4.21	12.22	6.76	4.25	4.66	4.67	3.21	2.56	1.85	0.86
Current Ratio	2.19	2.46	7.53	6.72	3.6	4.95	13.91	8.21	5.55	5.97	5.75	4.13	3.95	4.2	2.32
Quick Ratio	2.11	2.44	7.24	5.77	3.15	4.28	12.56	7.13	4.61	5	5.06	3.63	3.23	2.74	1.33
CFO/Avg Current Liab	-0.71	-0.6	-1.13	-3.53	-3.01	-3.57	-2.83	-2.97	-2.08	0.32	-1.02	-0.61	-0.79	-0.3	-0.22
Common Equity/Total Assets	57.05	60.33	84.78	83.94	69.53	79.39	60.34	62.86	44.89	25.52	29.48	12.31	26.32	38.55	34.05
Long-Term Debt/Equity (%)	5.66	1.35	0.64	1.51	7.86	1.79	53.84	40.74	89.18	140.84	122.67	416.12	148.19	87.03	90.16
Long-Term Debt/Capital (%)	5.35	1.33	0.63	1.47	7	1.71	34.82	28.95	47.14	58.48	54.69	80	56.44	46.31	47.16
Long-Term Debt/Total Assets (%)	3.23	0.81	0.54	1.27	5.47	1.42	32.48	25.61	40.03	35.95	36.16	51.2	39.01	33.55	30.7
Total Debt/Equity (%)	5.94	1.42	0.67	2.56	12.29	4.8	54.62	40.74	89.18	140.84	124.29	420.15	162.54	87.91	91.16
Total Debt/Capital (%)	5.61	1.4	0.67	2.49	10.95	4.58	35.32	28.95	47.14	58.48	55.42	80.77	61.91	46.78	47.69
Total Debt/Total Assets (%)	3.39	0.86	0.57	2.14	8.55	3.81	32.96	25.61	40.03	35.95	36.64	51.7	42.79	33.89	31.04
CFO/Total Liabilities	-101.4	-36.52	-145.78	-271.29	-179.14	-281.22	-44.72	-63.74	-45.44	4.83	-19.96	-11.86	-20.83	-8.45	-9.3
CFO/CapEx	-10.27	-25.93	-17.14	-4.79	-30.93	-35.8	-10.94	-6.04	-7.28	1.31	-10.86	-10.09	-5.74	-1.4	-1.87
Altman's Z-Score	-6.98	3.4	7.74	3.66	5.96	5.16	3.66	6.69	4.08	2.7	1.26	1.22	1.16	2.78	-0.91

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	13.71	8.95	3.45	3.28	0.39	1.18	9.16	7.84	5.49	5.65	5.53	5.08	4.04	3.8	4.4
Days Sales Outstanding	26.63	40.8	105.8	111.22	931.14	309.89	39.86	46.55	66.45	64.63	66.01	71.91	90.26	96.17	83.04
Inventory Turnover	- -	- -	- -	- -	- -	0.02	0.15	0.33	0.38	0.31	0.46	0.72	0.57	0.59	1.01
Days Inventory Outstanding	- -	- -	- -	- -	- -	23,152.2	2,393.08	1,115.77	957.31	1,161.36	786.37	508.67	639.51	613.57	361.85
Accounts Payable Turnover	- -	- -	- -	- -	- -	0.52	4.1	3.6	2.01	1.38	0.55	1.83	2.06	3.93	4.06
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	705.52	89.11	101.52	181.44	263.79	668.21	199.7	176.78	92.78	89.99
Cash Conversion Cycle	- -	- -	- -	- -	- -	22,756.57	2,343.83	1,060.81	842.32	962.2	184.17	380.87	553	616.96	354.89
Inventory to Cash Days	- -	- -	- -	- -	- -	-22,842.31	-2,353.21	-1,069.22	-890.86	-1,096.73	-720.36	-436.76	-549.25	-517.39	-278.81
Inventories	- -	- -	- -	- -	- -	13	84	125	171	232	186	204	323	750	915
Raw Materials	- -	- -	- -	- -	- -	10	54	71	82	72	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	3	27	47	88	140	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	2	7	1	21	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	186	204	323	750	915

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	102	818	769	598	1,760	1,502	3,605	7,756	9,702	13,533	7,846	11,397	9,039	11,782	2,259
- Cash & Cash Equivalents	40	188	257	74	80	122	600	371	835	1,503	2,116	967	428	1,103	801
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	2	2	6	23	16	431	421	730	1,073	1,153	1,617	1,397	1,343	1,040
Enterprise Value	64	632	514	394	1,591	1,200	2,957	7,003	9,307	12,667	6,883	11,025	8,759	11,770	2,359
Total Capital	33	125	249	254	214	353	1,220	1,453	1,548	1,835	2,081	2,002	2,256	2,871	2,180
Total Debt/Capital (%)	5.61	1.4	0.67	2.49	10.95	4.58	35.32	28.95	47.14	58.48	55.42	80.77	61.91	46.78	47.69
Total Debt / EV	0.03	- -	- -	0.02	0.01	0.01	0.15	0.06	0.08	0.08	0.17	0.15	0.16	0.11	0.44
EV/Sales	1.36	16.93	36.13	40.36	1,269.99	221.43	19.13	23.26	24.44	23.45	9.81	11.82	7.04	6.19	1.07
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.01	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.97	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	75.61	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	50.72	- -	- -	- -	- -	- -
Diluted Market Cap	97	609	690	579	1,632	1,336	3,273	7,230	9,499	13,291	7,318	11,346	8,910	13,117	2,098
Diluted Enterprise Value	59	423	434	512	1,575	1,229	3,104	7,280	9,394	12,861	6,355	11,996	9,878	13,357	2,337
EV per Share	2.82	19.94	13.61	9.53	34.87	21.92	45.64	98.53	123.78	159.58	79	125.35	93.45	121.47	22.47
TTM Sales	47	37	14	10	1	5	155	301	381	540	702	933	1,243	1,902	2,198
TTM EBITDA	-35	-28	-89	-130	-215	-259	-135	-331	-498	-537	-412	-494	-223	256	-613
TTM Operating Income	-36	-30	-90	-134	-220	-264	-143	-344	-522	-564	-450	-536	-268	218	-658
TTM Cash Flow to Firm	-24	-30	-65	-129	-148	-244	-226	-355	-426	168	-380	-271	-478	-189	-167
TTM Free Cash Flow to Firm	-21	-29	-61	-102	-143	-237	-205	-291	-363	250	-339	-239	-391	-42	-57

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-4.55	-21.33	-11.32	-5.69	-11.28	-5.59	-15.53	-22.29	-24.13	70.07	-18.19	-38.71	-21.54	-222.95	-21.94
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	53.97	- -
Enterprise Value	64	632	514	394	1,591	1,200	2,957	7,003	9,307	12,667	6,883	11,025	8,759	11,770	2,359
Low Price	3	3.3	12.12	12.58	11.33	8	26.26	50.68	72.05	78.06	65.3	61.28	55.25	91.34	10.42
EV/Sales	1.36	16.93	36.13	40.36	1,269.99	221.43	19.13	23.26	24.44	23.45	9.81	11.82	7.04	6.19	1.07
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	46.01	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	49.14	- -
Price/Earnings Average	-81.02	-2.31	-10.06	-7.11	-4.84	-4.85	-45.42	-19.4	-12.06	-19.39	-16.02	-11.44	-20.13	51.73	-6.01
Price/Earnings High	-153.19	-8.76	-16.81	-11.79	-8.07	-11.61	-66.8	-32.31	-16.35	-25.58	-33.86	-16.69	-27.56	70.02	-17.04
Price/Earnings Low	-27.95	-0.64	-3.66	-3.71	-2.18	-1.46	-30.47	-9.28	-7.42	-10.98	-12.67	-7.63	-9.52	36.92	-1.37
Price/Book Value	3.28	6.61	3.11	2.41	9.25	4.46	4.57	7.51	11.86	17.76	8.45	29.61	10.52	7.71	1.98
Price/Book Value Average	6.34	3.04	5.08	4.02	6.04	4.33	3.21	7.29	10.76	14.36	7.75	20.99	12.74	8.12	4.22
Price/Book Value High	11.99	11.54	8.49	6.67	10.06	10.37	4.73	12.15	14.59	18.95	16.38	30.63	17.44	10.99	11.95
Price/Book Value Low	2.19	0.85	1.85	2.1	2.72	1.3	2.16	3.49	6.62	8.13	6.13	14	6.03	5.79	0.96
Price/Tangible Book Value	3.88	6.89	3.18	2.47	9.58	4.57	4.65	7.6	12.04	18.09	8.59	30.2	10.89	7.85	2.03
Price/Tangible Book Value Average	7.49	3.17	5.19	4.12	6.26	4.44	3.27	7.38	10.93	14.62	7.87	21.41	13.19	8.26	4.32
Price/Tangible Book Value High	14.17	12.01	8.67	6.84	10.42	10.62	4.81	12.29	14.82	19.29	16.64	31.25	18.06	11.19	12.26
Price/Tangible Book Value Low	2.59	0.88	1.89	2.15	2.81	1.33	2.2	3.53	6.72	8.28	6.23	14.28	6.24	5.9	0.98
Price/Sales	2.07	16.31	48.49	59.36	1,302.11	246.4	21.17	24.02	24.94	24.61	10.43	12.16	7.17	6.08	0.92
Price/Sales Average	4	7.5	79.25	98.89	850.2	239.29	14.89	23.32	22.64	19.89	9.56	8.62	8.68	6.4	1.95
Price/Sales High	7.56	28.45	132.39	164.09	1,416.53	572.49	21.9	38.84	30.7	26.24	20.2	12.58	11.88	8.66	5.53
Price/Sales Low	1.38	2.09	28.85	51.61	382.4	71.86	9.99	11.15	13.93	11.27	7.56	5.75	4.11	4.57	0.44
Price/Cash Flow	-4.1	-20.51	-10.66	-4.51	-10.92	-5.43	-14.11	-18.6	-20.81	123.67	-16.51	-34.87	-17.78	-56.18	-9.8
Price/Cash Flow Average	-7.93	-9.43	-17.42	-7.51	-7.13	-5.28	-9.92	-18.06	-18.89	99.98	-15.14	-24.73	-21.54	-59.14	-20.87
Price/Cash Flow High	-15	-35.77	-29.1	-12.46	-11.88	-12.62	-14.6	-30.09	-25.61	131.9	-32	-36.08	-29.49	-80.04	-59.16
Price/Cash Flow Low	-2.74	-2.62	-6.34	-3.92	-3.21	-1.58	-6.66	-8.64	-11.62	56.62	-11.97	-16.49	-10.19	-42.2	-4.75
Price/Free Cash Flow Average	-8.79	-9.81	-18.5	-9.49	-7.37	-5.43	-10.92	-21.64	-21.9	56.65	-16.67	-27.45	-26.08	-234.71	-46.7
Price/Free Cash Flow High	-16.61	-37.2	-30.9	-15.74	-12.27	-12.99	-16.06	-36.05	-29.69	74.73	-35.24	-40.05	-35.72	-317.68	-132.37
Price/Free Cash Flow Low	-3.03	-2.73	-6.73	-4.95	-3.31	-1.63	-7.33	-10.35	-13.47	32.08	-13.19	-18.31	-12.34	-167.48	-10.62
EV/Sales Average	3.38	5.1	70.43	95.18	871.92	249.48	15.32	25.18	22.85	19.46	8.88	9.36	9.58	6.65	2.3
EV/Sales High	7.11	33.24	129.69	162.47	1,482.97	624.15	23.04	41.84	31.07	25.93	20.29	13.34	12.83	8.95	6.31
EV/Sales Low	0.63	- -	14.22	46.37	367.18	61.21	9.92	12.13	13.95	10.68	6.73	6.47	4.94	4.78	0.61
EV/EBITDA Average	-4.58	-6.75	-11.25	-7.14	-5.08	-5.23	-17.52	-22.87	-17.48	-19.56	-15.14	-17.66	-53.32	49.43	-8.23
EV/EBITDA High	-9.64	-44.03	-20.72	-12.18	-8.65	-13.09	-26.36	-38	-23.77	-26.06	-34.59	-25.17	-71.41	66.57	-22.61
EV/EBITDA Low	-0.86	2.88	-2.27	-3.48	-2.14	-1.28	-11.34	-11.02	-10.67	-10.73	-11.48	-12.22	-27.51	35.54	-2.17
EV/EBIT Average	-4.42	-6.4	-11.09	-6.94	-4.96	-5.12	-16.53	-22.06	-16.66	-18.63	-13.86	-16.28	-44.48	57.98	-7.67
EV/EBIT High	-9.29	-41.77	-20.43	-11.85	-8.44	-12.81	-24.87	-36.65	-22.66	-24.82	-31.67	-23.21	-59.57	78.08	-21.08
EV/EBIT Low	-0.83	2.74	-2.24	-3.38	-2.09	-1.26	-10.7	-10.63	-10.17	-10.22	-10.51	-11.26	-22.95	41.69	-2.03
Last Price	4.5	25.8	20.37	14.47	38.58	27.43	55.64	109.13	129.04	170.49	90.05	129.58	96.43	121.59	21.52
High Price	16.44	45	55.61	40	41.97	63.73	57.57	176.5	158.8	181.83	174.49	134.08	159.89	173.25	129.84
Enterprise Value Average	159	190	1,001	929	1,093	1,352	2,368	7,580	8,701	10,510	6,231	8,731	11,914	12,643	5,046
Enterprise Value High	334	1,241	1,844	1,585	1,858	3,384	3,561	12,594	11,834	14,003	14,240	12,443	15,955	17,028	13,867
Enterprise Value Low	30	-81	202	452	460	332	1,533	3,652	5,312	5,766	4,727	6,040	6,147	9,091	1,332

Shares Outstanding	23	32	38	41	46	55	65	71	75	79	87	88	94	97	105
Diluted Weighted Avg Shares	22	24	34	40	42	49	59	66	74	78	81	88	92	108	97
Basic Weighted Avg Shares	22	24	34	40	42	49	59	66	74	78	81	88	92	95	94
Revenue per Share	2.18	1.58	0.42	0.24	0.03	0.11	2.63	4.54	5.17	6.93	8.64	10.66	13.46	20.01	23.48
EBITDA per Share	-1.6	-1.19	-2.63	-3.25	-5.08	-5.31	-2.3	-5	-6.76	-6.89	-5.07	-5.65	-2.42	2.69	-6.55
Operating Income per Share	-1.66	-1.26	-2.67	-3.34	-5.21	-5.43	-2.43	-5.19	-7.1	-7.24	-5.53	-6.12	-2.9	2.29	-7.03
Basic EPS, GAAP	-0.11	-5.14	-3.31	-3.39	-5.2	-5.49	-0.86	-5.46	-9.71	-7.11	-5.15	-8.03	-5.8	2.47	-7.62
Basic EPS from Cont Ops	-0.11	-5.14	-3.31	-3.39	-5.2	-5.49	-0.86	-5.46	-9.71	-7.11	-5.15	-8.03	-5.8	2.47	-7.62
Diluted EPS, GAAP	-0.11	-5.14	-3.31	-3.39	-5.2	-5.49	-0.86	-5.46	-9.71	-7.11	-5.15	-8.03	-5.8	2.18	-7.32
Diluted EPS from Cont Ops	-0.11	-5.14	-3.31	-3.39	-5.2	-5.49	-0.86	-5.46	-9.71	-7.11	-5.15	-8.03	-5.8	2.18	-7.32
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.1	-1.26	-1.91	-3.21	-3.53	-5.05	-3.94	-5.87	-6.2	1.38	-5.45	-3.72	-5.42	-2.16	-2.19
Free Cash Flow per Basic Share	-1.2	-1.31	-2.02	-3.88	-3.65	-5.19	-4.3	-6.84	-7.05	0.32	-5.96	-4.08	-6.37	-3.71	-3.37
Cash & Equivalents per Share	1.76	5.92	6.81	5.09	4.22	5.8	16.65	16.52	14.96	24.42	24.28	22.62	17.88	13.98	8.95
Book Value per Share	1.37	3.9	6.55	5.99	4.17	6.15	12.18	14.52	10.88	9.6	10.65	4.38	9.17	15.77	10.87
Tangible Book Value per Share	1.16	3.75	6.41	5.85	4.03	6	11.96	14.36	10.72	9.43	10.49	4.29	8.85	15.49	10.59

Sarepta Therapeutics, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)